Sandra E. Poole
Director/Board Member at TRAVERE THERAPEUTICS, INC.
Net worth: 126 665 $ as of 2024-04-29
Sandra E. Poole active positions
Companies | Position | Start | End |
---|---|---|---|
TRAVERE THERAPEUTICS, INC. | Director/Board Member | 2019-05-12 | - |
Independent Dir/Board Member | 2019-05-12 | - | |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director/Board Member | 2019-06-26 | - |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Chief Operating Officer | 2020-06-30 | - |
Career history of Sandra E. Poole
Former positions of Sandra E. Poole
Companies | Position | Start | End |
---|---|---|---|
VALNEVA | Director/Board Member | 2017-06-29 | 2020-06-16 |
Independent Dir/Board Member | 2017-06-29 | 2020-06-16 | |
CANDEL THERAPEUTICS, INC. | Chief Operating Officer | 2020-01-09 | 2020-02-29 |
LOGICBIO THERAPEUTICS, INC. | Chief Operating Officer | 2018-03-31 | 2019-03-30 |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services S. Poole Consulting LLC provides business consulting services. The private company is based in Boston, MA. | Corporate Officer/Principal | 2016-07-31 | 2018-02-28 |
IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | 2014-09-16 | 2016-12-31 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 1999-01-31 | 2014-08-31 |
Training of Sandra E. Poole
The University of Waterloo | Graduate Degree |
Statistics
International
United States | 9 |
Canada | 2 |
France | 2 |
Operational
Chief Operating Officer | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CANDEL THERAPEUTICS, INC. | Health Technology |
VALNEVA | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services S. Poole Consulting LLC provides business consulting services. The private company is based in Boston, MA. | Commercial Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sandra E. Poole
- Experience